Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:analyzes |
statistical methods
clinical researchers |
| gptkbp:clinicalTrials |
pending
required randomized controlled trial Phase 1/2 evaluate safety and efficacy early phase NCT03399064 potential cure |
| gptkbp:collaborations |
gptkb:University_of_California,_San_Francisco
|
| gptkbp:collection |
clinical assessments
|
| gptkbp:community_service |
under investigation
defined |
| gptkbp:communityEngagement |
patient advocacy groups
|
| gptkbp:court |
several years
|
| gptkbp:customerFeedback |
collected
|
| gptkbp:dataUsage |
with research community
|
| gptkbp:developedBy |
gptkb:Sangamo_Therapeutics
|
| gptkbp:evaluates |
under investigation
|
| gptkbp:firstAwarded |
2018
|
| gptkbp:firstClaim |
long-term remission
|
| gptkbp:future_plans |
Phase 1
|
| gptkbp:hasPopulation |
HIV-positive individuals
|
| gptkbp:hasPrograms |
established
|
| gptkbp:healthcare |
ongoing
ongoing throughout trial |
| gptkbp:historicalResearch |
academic institutions
gene therapy advancements |
| https://www.w3.org/2000/01/rdf-schema#label |
SR 925
|
| gptkbp:impact |
standardized
viral suppression |
| gptkbp:includes |
HIV-positive adults
severe comorbidities |
| gptkbp:is_studied_in |
multiple sites
|
| gptkbp:mandates |
HIV infection
|
| gptkbp:moral |
obtained
|
| gptkbp:outcome |
viral load
|
| gptkbp:publications |
scientific journals
|
| gptkbp:regulatoryCompliance |
investigational new drug
not yet obtained |
| gptkbp:research |
grants and donations
biomedical research private investment |
| gptkbp:researchAndDevelopment |
to be published
|
| gptkbp:researchFocus |
gene editing
|
| gptkbp:researchInterest |
improve patient outcomes
international partners compliance required technical complexities clinical trial methodology HIV_treatment_strategies |
| gptkbp:route |
intravenous
|
| gptkbp:safetyFeatures |
under evaluation
|
| gptkbp:scientificName |
gene editing technology
|
| gptkbp:secondaryMission |
immune response
|
| gptkbp:sideEffect |
to be determined
|
| gptkbp:sponsor |
gptkb:Sangamo_Therapeutics
|
| gptkbp:status |
clinical trial
|
| gptkbp:targets |
HIV
|
| gptkbp:ticketingSystem |
lentiviral vector
|
| gptkbp:triggerType |
Zinc finger nuclease
|
| gptkbp:type |
gene therapy
|